Radiation therapy for women with breast cancer will now last for no more than three weeks
The HypoG-01 study, led by Dr. Sofia Rivera, shows that a 3-week hypofractionated radiation therapy is equivalent to a 5-week normofractionated therapy for locoregional breast cancer, setting a new standard of care.
Reference News
Radiation therapy for women with breast cancer will now last for no more than three weeks
The HypoG-01 study, led by Dr. Sofia Rivera, shows that a 3-week hypofractionated radiation therapy is equivalent to a 5-week normofractionated therapy for locoregional breast cancer, setting a new standard of care.